Key result
Myocardial injury IHC markers lack validation in the cardiac conduction system across 32 studies.
Why the study?
Postmortem timing of early myocardial injury is a major forensic challenge, and although immunohistochemical markers have been investigated in working ventricular myocardium, the histologically and molecularly distinct cardiac conduction system (CCS) has received remarkably little attention.
Can immunohistochemical markers established for postmortem injury dating in working ventricular myocardium be validly extrapolated to the cardiac conduction system in forensic investigations?
Can immunohistochemical markers established for postmortem injury dating in working ventricular myocardium be validly extrapolated to the cardiac conduction system in forensic investigations?
Extrapolating ventricular immunohistochemical timelines to the cardiac conduction system lacks empirical support due to distinct baseline protein and connexin expression, posing a substantial risk of diagnostic error in forensic investigations of sudden cardiac and unexplained deaths.
Caution advised against extrapolating ventricular timelines to conduction system dating in forensics; leaves open need for tissue-specific validation studies.
The postmortem timing of myocardial injury remains a major challenge in forensic pathology, particularly when conventional histological methods are insufficient during the early hours after an ischemic insult. We conducted a critical narrative review of immunohistochemical markers for myocardial injury dating, focusing on their biological applicability to the cardiac conduction system (CCS). The search was performed using PubMed and Scopus; no date restriction was applied. Over the past three decades, markers including complement components (C5b-9), cardiac troponins, fibronectin, and connexin 43 have been investigated, with varying degrees of validation, for injury dating in working ventricular myocardium. However, the CCS — comprising the sinoatrial node, atrioventricular node, bundle of His, and Purkinje fibers — is a histologically and molecularly distinct tissue that has received remarkably little attention in this context. We highlight fundamental differences in cellular composition, connexin expression profiles, extracellular matrix content, and baseline protein abundance between conduction and ventricular tissue that are likely to significantly alter marker behavior and temporal kinetics. The direct application of ventricular-based immunohistochemical timelines to the CCS lacks empirical support and may lead to forensic misinterpretation. The medico-legal implications are potentially significant, as accurate timing of conduction system injury is relevant to cases of sudden unexplained death, drug-induced arrhythmias, blunt cardiac trauma, and medical negligence litigation. Systematic, tissue-specific validation studies are urgently needed.
No takes yet. Share an insight, caveat, or question.
Aktar et al. (2026) conducted a review in Cardiac conduction system injury and sudden cardiac death. Immunohistochemical markers (C5b-9, cardiac troponins, fibronectin, dystrophin, desmin, connexin 43, H-FABP, myoglobin, CD15, CD68) vs. Working ventricular myocardium vs. cardiac conduction system tissue was evaluated on Validation and biological applicability of immunohistochemical markers for dating injury in the cardiac conduction system. Immunohistochemical markers for dating myocardial injury (C5b-9, troponins, fibronectin, Cx43) have 0 tissue-specific validation studies in the cardiac conduction system across 32 reviewed studies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: